Live Breaking News & Updates on Jessica hamzelou

Stay informed with the latest breaking news from Jessica hamzelou on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Jessica hamzelou and stay connected to the pulse of your community

Combating covid, and the challenges of governing AI | MIT Technology Review

Elon Musk pulled the plug on Starlink satellites to disrupt a Ukrainian mission

Australia , Ryan-salame , Jill-biden , Jeffrey-longoria , Cassandra-willyard , Palmer-luckey , Jessica-hamzelou , Microsoft , Burning-man , Combating-covid , Nd-the-challenges-of-governing-ai ,

Open source's future, and cancer drugs shortages | MIT Technology Review

AI is worming its way into academic journals

Toronto , Ontario , Canada , Spain , San-francisco , California , United-states , Mexico-city , Distrito-federal , Mexico , Brian-eno , Rebecca-ackermann

Abortion Pill's Legal Limbo Continues | KFF Health News

A federal appeals court issued a split decision on whether the abortion pill mifepristone should remain on the market — rejecting a lower court’s decision to effectively cancel the drug’s FDA approval in 2000, while ordering the rollback of more recent rules that made the drug easier to obtain. Nothing changes immediately, however, as the Supreme Court blocked the lower court’s ruling in the spring. It will be up to the high court to determine whether the pill remains available in the U.S. and under which conditions. Sarah Karlin-Smith of the Pink Sheet, Alice Miranda Ollstein of Politico, and Shefali Luthra of The 19th join KFF Health News’ chief Washington correspondent, Julie Rovner, to discuss these issues and more. Plus, for “extra credit,” the panelists suggest health policy stories they read this week they think you should read, too.

United-states , Texas , Washington , American , Katherine-ellen-foley , Sarah-karlin-smith , Erin-schumaker , Julie-rovner , Shefali-luthra , Alice-miranda-ollstein , Francis-ying , Emmarie-huetteman

Abortion Pill's Legal Limbo Continues | California Healthline

A federal appeals court issued a split decision on whether the abortion pill mifepristone should remain on the market — rejecting a lower court’s decision to effectively cancel the drug’s FDA approval in 2000, while ordering the rollback of more recent rules that made the drug easier to obtain. Nothing changes immediately, however, as the Supreme Court blocked the lower court’s ruling in the spring. It will be up to the high court to determine whether the pill remains available in the U.S. and under which conditions. Sarah Karlin-Smith of the Pink Sheet, Alice Miranda Ollstein of Politico, and Shefali Luthra of The 19th join KFF Health News’ chief Washington correspondent, Julie Rovner, to discuss these issues and more. Plus, for “extra credit,” the panelists suggest health policy stories they read this week they think you should read, too.

Washington , United-states , Texas , American , Jessica-hamzelou , Julie-rovner , Francis-ying , Sarah-karlin-smith , Emmarie-huetteman , Katherine-ellen-foley , Erin-schumaker , Alice-miranda-ollstein

KFF Health News' 'What the Health?': Abortion pill's legal limbo continues

A divided three-judge federal appeals court panel has ruled that a lower court was wrong to try to reverse entirely the FDA's approval of the abortion drug mifepristone.

Texas , United-states , Washington , American , Jessica-hamzelou , Sarah-karlin-smith , Erin-schumaker , Shefali-luthra , Lily-ramsey , Katherine-ellen-foley , Kaiser-permanente , Julie-rovner

The Download: medical ethics, and AI watermarks

This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. Who gets to decide who receives experimental medical treatments? There has been a trend toward lowering the bar for new medicines, and it is becoming easier for people to access treatments that might…

White-house , District-of-columbia , United-states , James-surowiecki , Gyozanomise-okei , Big-four , Claire-leibowicz , Jessica-hamzelou , Casey-crownhart , Media-integrity-program , Facebook , Big-tech

egenesis: eGenesis plans to transplant gene-edited pig hearts into human babies by next year

Biotech company eGenesis aspires to transplant pig hearts into babies with serious heart defects. The goal is to buy them more time to wait for a human heart. But before that happens, the team at eGenesis will practice on 12 infant baboons. Two such surgeries have been performed so far.

Eli-katz , Jessica-hamzelou , Jessica-hamzelou-the , Egenesis , Montgomery , Mike-curtis , Nyu , Biotech ,

Heart transplants for babies, and Big Tech's tax tracking

The AI backlash, explained

Israel , Mali , Ukraine , Tate-ryan-mosley , Jessica-hamzelou , Sam-bowman , Bloomberg , Twitter , York-university , Reuters , Un-security-council , Google

Tricking AI text-detectors, and covid's unanswered questions

Twitter has threatened to sue Meta

Brazil , Washington , United-states , New-york , Rhiannon-williams , Jessica-hamzelou , Abby-ohlheiser , Evadne-eddins , Sony , Twitter , Washington-post , Reuters

Gene-edited microbiomes, and Google's Canadian standoff

The US Supreme Court's latest ruling has grave significance for victims of online harassment

Jessica-hamzelou ,